Safranal inhibited the growth of GBM cells in vitro and in vivo by promoting GBM cell apoptosis, causing G2/M phase arrest, and inhibiting the PI3K/AKT/mTOR axis. The gene discussed is MTOR; the disease is glioblastoma.